NCR1 and neoplasm: Moreover, unlike CAR-T cells, the genetic modification of NK cells with CAR does not seem to alter the repertoire of the activating receptors, and these cells can still recognize and kill tumor cells via the activating NK receptors (e.g., NKp46, NKp30, NKG2D).